Global Ortho Phthalic Aldehyde demand is anticipated to be valued at US$ 5.3 Billion in 2022, forecast to grow at a CAGR of 5.2%to be valued at US$ 8.8 Billion from 2022 to 2032. The spike in the market for equipment sterilization and disinfectants is regarded as the primary growth factor in the worldwide ortho phthalic aldehyde market.
| Report Attribute | Details |
|---|---|
| Estimated Base Year Value (2021) | US$ 5 Billion |
| Expected Market Value (2022) | US$ 5.3 Billion |
| Anticipated Forecast Value (2032) | US$ 8.8 Billion |
| Projected Growth Rate (2022 to 2032) | 5.2% CAGR |
Traditionally, Ortho Phthalic Aldehyde was widely used as a refrigerant. However, Ortho-Phthalic Aldehyde, also known as o-Phthalaldehyde, is a chemical compound that was approved by the FDA in October 1999. It is frequently abbreviated as OPA. This light yellow solid substance is used in the construction of pharmacompounds. Ortho-Phthalic Aldehyde, commonly known as Fluoraldehyde Crystals, is a fluorescent derivatization reagent with great sensitivity for diverse microbiocidal actions.
Its excellent material compatibility, along with a hardly discernible odor, eliminates the need for exposure monitoring. As a result, Ortho-Phthalic Aldehyde is increasingly being employed in the healthcare business as a substitute for glutaraldehyde, which is better recognized as a sensitizer. Furthermore, it has revealed higher antimycobactericidal action, allowing it to be used at lower doses. However, in order to safeguard visitors, staff, and patients, it must be used in accordance with the manufacturer's instructions.
Ortho-Phthalic Aldehyde market prospects are increasing due to various possible benefits, including the fact that it does not require activation and is not irritating to the eyes or nasal passages. Ortho-Phthalic Aldehyde exhibits high stability throughout a wide range of PH, i.e. PH3-9, and no exposure monitoring is performed.
The growing scope of innovation to manufacture efficient and safe chemicals, as well as the growth in the sterilizing equipment and disinfectants industry, are the main drivers for the ortho-Phthalic Aldehyde market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The growing cost of raw materials, as well as environmental and regulatory difficulties, are some of the major challenges confronting the Ortho-Phthalic Aldehyde market.
Because of the region's fast-growing economy, Asia Pacific accounts for the highest proportion of the worldwide ortho phthalic aldehyde market. Furthermore, expanding government activities to stimulate the expansion of the chemical, construction, and other sectors would positively affect the regional market's trajectory.
Principal Consultant
According to Future Market Insights, based on the increased preference for ortho phthalic aldehyde over glutaraldehyde in a variety of applications, including high-level disinfection, North America is likely to be the leading region in the worldwide ortho phthalic aldehyde market in the coming years.
The increased popularity can be due to its stability across a wide pH range, as well as the fact that it does not require activation. However, the government is supporting recyclable and reusable items in the region to encourage sustainable development, which is anticipated to aid in the growth of the regional market because ortho phthalic aldehyde solution may be reused for around 14 days. The expanding number of hospitals and clinics in the region, as a result of the increasing frequency of numerous infectious illnesses, will create a significant need for hospital waste sterilization, disinfection, and control. This increase in demand will drive up the demand for ortho phthalic aldehyde compounds in the region.
Some of the key participants present in the global Ortho Phthalic Aldehyde market include MP Biomedicals, LLC. Sigma-Aldrich Co. LLC., TCI America, Parchem fine & specialty chemicals, DPx Fine Chemicals, Thermo Fisher Scientific Inc., Merck Millipore Corporation, Alfa Aesar, A Johnson Matthey Company, and AK Scientific Inc among others.
Attributed to the presence of such high number of participants, the market is highly competitive.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 5.2% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | End Use, Application, Region |
| Regions Covered | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand,China, India, ASEAN, GCC, South Africa |
| Key Companies Profiled | MP Biomedicals; LLC.; Sigma-Aldrich Co. LLC.; TCI America; Parchem fine & specialty chemicals; DPx Fine Chemicals; Thermo Fisher Scientific Inc.; Merck Millipore Corporation; Alfa Aesar; A Johnson Matthey Company; AK Scientific Inc |
| Customization | Available Upon Request |
End Use:
Application:
Region:
FMI projects the global Ortho Phthalic Aldehyde market to expand at a 5.2% value CAGR by 2032
North America is expected to be the most opportunistic Ortho Phthalic Aldehyde market.
MP Biomedicals, LLC. Sigma-Aldrich Co. LLC., TCI America, Parchem fine & specialty chemicals, DPx Fine Chemicals, Thermo Fisher Scientific Inc., Merck Millipore Corporation, Alfa Aesar, A Johnson Matthey Company, and AK Scientific Inc are some prominent Ortho Phthalic Aldehyde manufacturers
Explore Chemicals & Materials Insights
View Reports
Ortho Phthalic Aldehyde Market
